Veloce BioPharma LLC
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://velocebiopharma.com
Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Topical 2% Povidone-Iodine Gel in Verruca Vulgaris
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Veloce BioPharma LLC
- Target Recruit Count
- 90
- Registration Number
- NCT04253912
- Locations
- 🇺🇸
Veloce BioPharma Clinical Trial Site, Lynchburg, Virginia, United States
A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients
- First Posted Date
- 2017-07-05
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Veloce BioPharma LLC
- Target Recruit Count
- 102
- Registration Number
- NCT03207906
- Locations
- 🇺🇸
Compassionate Cancer Care, Fountain Valley, California, United States
🇺🇸Northwestern University Department of Dermatology, Chicago, Illinois, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: VBP-245 Topical GelDrug: Vehicle
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Veloce BioPharma LLC
- Target Recruit Count
- 110
- Registration Number
- NCT03077750
- Locations
- 🇺🇸
Philadelphia Institute of Dermatology, Fort Washington, Pennsylvania, United States
🇺🇸Parkside Pediatrics, Greenville, South Carolina, United States
🇺🇸Coastal Pediatrics, Mount Pleasant, South Carolina, United States
ALC-919 For The Treatment Of Common Warts
- Conditions
- Verruca Vulgaris
- Interventions
- Drug: Vehicle-Control Topical Solution
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- Veloce BioPharma LLC
- Target Recruit Count
- 21
- Registration Number
- NCT02483455
- Locations
- 🇺🇸
Philadelphia Institute of Dermatology, Fort Washington, Pennsylvania, United States